Jose A. Fontenla
Santiago De Compostela, GA 15782, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Achyrocline satureioides: in silico and in vivo evaluation of the potential neuroprotective effect of the aqueous extract.
Journal: Journal of ethnopharmacology
Published: April 10, 2025
Gamma-Decanolactone Increases Stress Resistance and Improves Toxicity Parameters on the Caenorhabditis elegans Alternative Model.
Journal: Journal of applied toxicology : JAT
Published: July 09, 2024
Toxicological assessment of the Achyrocline satureioides aqueous extract in the Caenorhabditis elegans alternative model.
Journal: Journal of toxicology and environmental health. Part A
Published: June 21, 2024
8-Amide and 8-carbamate substitution patterns as modulators of 7-hydroxy-4-methylcoumarin's antidepressant profile: Synthesis, biological evaluation and docking studies.
Journal: European journal of medicinal chemistry
Published: September 30, 2022
Gamma-decanolactone: Preliminary evaluation as potential antiparkinsonian drug.
Journal: European journal of pharmacology
Published: April 04, 2021
Gamma-decanolactone attenuates acute and chronic seizures in mice: a possible role of adenosine A1 receptors.
Journal: Behavioural pharmacology
Published: July 24, 2020
Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy.
Novel coumarin-pyridazine hybrids as selective MAO-B inhibitors for the Parkinson's disease therapy.
Journal: Bioorganic chemistry
Published: May 22, 2020
Discovery and optimization of 3-thiophenylcoumarins as novel agents against Parkinson's disease: Synthesis, in vitro and in vivo studies.
Journal: Bioorganic chemistry
Published: April 29, 2020
Anxiolytic-Like Effects of 7H-Benzo[e]perimidin-7-One Derivatives through Elevated Plus-Maze Test in Mice.
Journal: Current topics in medicinal chemistry
Published: January 13, 2015
Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases.
Journal: Future medicinal chemistry
Published: March 19, 2014
Last Updated: 09/26/2026